Get the Stockscreener App
8.68
0.81%
0.07
After Hours:
8.68
Sensei Biotherapeutics Inc stock is traded at $8.68, with a volume of 32,499.
It is up +0.81% in the last 24 hours and down -9.11% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$8.61
Open:
$8.6
24h Volume:
32,499
Relative Volume:
1.01
Market Cap:
$10.95M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-7.2941
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
-8.92%
1M Performance:
-9.11%
6M Performance:
+2.31%
1Y Performance:
-16.38%
1-Day Range:
$8.60
$8.99
1-Week Range:
$8.3312
$12.40
52-Week Range:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
8.68 | 10.86M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Identifying reversal signals in Sensei Biotherapeutics Inc.Weekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Long term hold vs stop loss in Sensei Biotherapeutics Inc.Entry Point & Free AI Powered Buy and Sell Recommendations - newser.com
How Sensei Biotherapeutics Inc. (4070) stock correlates with oil marketsJobs Report & Verified Short-Term Plans - newser.com
Measuring Sensei Biotherapeutics Inc.’s beta against major indices2025 Earnings Impact & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-11-04 01:32:47 - newser.com
Applying big data sentiment scoring on Sensei Biotherapeutics Inc.Earnings Risk Summary & Community Verified Watchlist Alerts - newser.com
Is Sensei Biotherapeutics Inc. (4070) stock protected from inflation2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
How geopolitical tensions affect Sensei Biotherapeutics Inc. stockEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Published on: 2025-11-03 07:12:45 - newser.com
Is Sensei Biotherapeutics Inc. stock in correction or buying zoneQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
Can Sensei Biotherapeutics Inc. stock deliver consistent earnings growthAnalyst Downgrade & Weekly High Momentum Picks - newser.com
Is Sensei Biotherapeutics Inc. stock reversal real or fakeMarket Trend Report & AI Optimized Trading Strategy Guides - newser.com
Using data models to predict Sensei Biotherapeutics Inc. stock movementMarket Risk Report & Reliable Trade Execution Plans - newser.com
How Sensei Biotherapeutics Inc. stock reacts to oil prices2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
What technical charts say about Sensei Biotherapeutics Inc. stock2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
How to build a custom watchlist for Sensei Biotherapeutics Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Sensei to ditch its lead candidate and cut workforce amidst strategic review - Yahoo Finance
Sensei Biotherapeutics discontinues cancer drug, explores alternatives By Investing.com - Investing.com Australia
Why hedge funds are buying Sensei Biotherapeutics Inc. stockTrade Volume Summary & Consistent Profit Alerts - newser.com
Custom strategy builders for tracking Sensei Biotherapeutics Inc.Weekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
Why Sensei Biotherapeutics Inc. is moving todayWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Leading vs lagging indicators on Sensei Biotherapeutics Inc. performanceWeekly Risk Summary & Capital Efficient Trading Techniques - newser.com
Can momentum traders help lift Sensei Biotherapeutics Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Published on: 2025-10-31 04:13:44 - newser.com
Published on: 2025-10-31 02:55:10 - newser.com
Published on: 2025-10-31 00:46:42 - newser.com
Published on: 2025-10-31 00:27:27 - newser.com
Published on: 2025-11-04 03:47:50 - newser.com
SNSE Downgraded to Neutral by HC Wainwright & Co. Analyst Matthe - GuruFocus
Sensei Biotherapeutics stock rating downgraded as company halts key drug By Investing.com - Investing.com Canada
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):